United States · FDA National Drug Code directory
Orphenadrine citrate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0641-6182_dde13b7f-78fb-4b9a-bc16-a41bf45042be
- Product NDC
- 0641-6182
- Form
- INJECTION
- Composition / generic term
- Orphenadrine citrate
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20030428
- Source listing expiry
- 20261231
Source-listed ingredients
- ORPHENADRINE CITRATE — 60 mg/2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 BOX in 1 BOX (0641-6182-25) / 10 VIAL in 1 BOX (0641-6182-10) / 2 mL in 1 VIAL (0641-6182-01) · 0641-6182-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →